Our latest news

  • Current opinions on managing nmCRPC and the implications of new imaging modalities
  • The NSTEMI Debate: Early vs. Late Treatment
  • Immunotherapy in gastroesophageal cancer
  • Treatment sequencing for mCRPC: Providing crucial support to the patient
  • Treatment sequencing for mCRPC: Providing crucial support to the patient
  • Current opinions on how to identify and treat NTRK fusion positive cancer
  • Devices in the Cath Lab
  • Highlights of 2020 in prostate, urothelial and kidney cancer
  • NTRK CONNECT provides an overview of the occurrence of NTRK fusions and TRK inhibitor therapy in GI cancer
  • Watch the webinar on demand: ACS Forum 2020